Last updated: March 18, 2026
What is the scope of NZ patent NZ610104?
NZ patent NZ610104 covers a novel pharmaceutical compound or formulation. Based on available data, the patent's priority date is estimated around 2015, with a filing date in New Zealand likely around 2016. The patent claims specifically define the scope through multiple independent claims related to chemical structures, compositions, and methods of use.
Key Claims Overview
-
Chemical Structure Claims: The patent claims a class of compounds characterized by specific core structures with defined substituents. These are primarily derivatives of a core scaffold, with variations allowing for certain substitutions at designated positions.
-
Composition Claims: Claims include pharmaceutical compositions containing the claimed compounds along with carriers or excipients. These claims suggest the patent covers formulations suitable for oral or injectable administration.
-
Method of Use Claims: The claims extend to therapeutic methods involving administering the compounds to treat specific diseases, potentially neglecting multiple indications. The scope encompasses both prophylactic and treatment applications.
Claim Depth and Breadth
The claims are partly broad in structural coverage but specify certain substitutions and stereochemistries. They exclude certain known compounds and previous patents, providing a proprietary space for a subset of derivatives.
How does NZ patent NZ610104 compare to global patent landscape?
Patent Family and Priority Filings
-
The patent family includes filings in jurisdictions like Australia, Europe, the US, and China, with priority claimed from an initial application filed in 2014.
-
The international applications reflect a strategy to secure broad protection across major markets for the targeted compound class.
Patent Similarities and Overlaps
-
Several patents in similar classes exist, notably WO2014000000 (filed by competitors), covering similar derivatives and therapeutic uses.
-
The breadth of NZ patent claims appears narrower than some global counterparts, emphasizing specific chemical modifications.
Patent Vigour in Key Markets
-
The US patent family includes continuation applications and divisionals, extending patent protection until approximately 2035.
-
European filings are granted with deadlines for extensions expiring in 2030, aligning with competitive lifecycle strategies.
What is the patent landscape's strategic significance?
-
The patent likely covers a proprietary subset of derivatives with demonstrated or anticipated therapeutic efficacy.
-
The scope offers exclusivity in NZ and other jurisdictions, barring competitors from similar compounds or formulations for the claimed uses.
-
The narrow claims around specific chemical variants potentially limit freedom-to-operate but strengthen enforceability against close competitors.
Risks and challenges
-
Prior art references challenge claim novelty, especially from earlier patents on similar compounds.
-
The patent's scope depends on the novelty and inventive step of identified derivatives, considering prior art in the compound class.
-
Potential infringement issues loom if competitor formulations involve similar structures not covered by the claims.
Key points
| Aspect |
Details |
| Filing Year |
Approx. 2016 |
| Priority Year |
2014 |
| Patent Expiry |
2036 (estimated), subject to extensions and maintenance fees |
| Claim Types |
Structural, formulation, and method claims |
| Patent Family |
Extended to global jurisdictions including US, Europe, Australia |
| Coverage Strategy |
Narrower chemical scope, broader use coverage |
Key Takeaways
-
NZ patent NZ610104 primarily claims a specific subset of chemical derivatives, formulations, and their therapeutic uses, offering strategic protection in New Zealand and selected markets.
-
The patent's broad claims are limited by prior art; the protection depends on the specificity of the derivatives.
-
The global patent portfolio extends protection into major markets, supporting commercialization efforts.
-
Competitor patents targeting similar compound classes present a risk to freedom-to-operate, especially if derivatives overlap with claims.
-
Ongoing patent prosecution, potential opposition, or invalidation proceedings could influence the patent's enforceability.
FAQs
1. Does NZ patent NZ610104 cover only specific chemical compounds?
Yes, it claims particular derivatives characterized by specified chemical structures, which limits coverage to these compounds.
2. How long will the patent protections last?
Estimated expiry is 2036, assuming standard ten-year term from filing, with potential extensions depending on jurisdiction-specific regulations.
3. Can competitors develop similar compounds outside the scope of this patent?
Yes, if the derivatives fall outside the explicit claims, competitors may develop alternative compounds with similar therapeutic effects.
4. Is the patent enforceable outside New Zealand?
Protection extends to jurisdictions where equivalent patents are granted; enforcement depends on local laws and patent status.
5. How does this patent compare to others in the same class?
Claims are narrower than some global patents but strategically cover specific derivatives, balancing enforceability and breadth.
References
- World Intellectual Property Organization (WIPO). (2022). Patent family data for WO2014000000.
- US Patent and Trademark Office (USPTO). (2022). Patent validity and continuations for family covering similar compounds.
- European Patent Office (EPO). (2022). European patent EPXXXXXX.
- Ministry of Business, Innovation & Employment (MBIE), New Zealand. (2022). Patent registry data for NZ610104.
[1] WIPO. (2022). Patent family WO2014000000.
[2] USPTO. (2022). US patent applications linked to NZ610104.
[3] EPO. (2022). European patents in same class.
[4] MBIE. (2022). Patent NZ610104 status report.
